MetLife Investment Management’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.44M	Buy	60,975 +677	+1%	+$17.3K	0.01%	1228
2025 Q4	$1.75M	Sell	60,298 -4,187	-6%	-$107K	0.01%	1150
2025 Q3	$1.22M	Hold	64,485	–	–	0.01%	1335
2025 Q2	$904K	Hold	64,485	–	–	0.01%	1369
2025 Q1	$1.01M	Sell	64,485 -986	-2%	-$13.9K	0.01%	1359
2024 Q4	$912K	Buy	65,471 +3,813	+6%	+$41.8K	﹤0.01%	1461
2024 Q3	$573K	Hold	61,658	–	–	﹤0.01%	1710
2024 Q2	$573K	Buy	61,658 +17,857	+41%	+$161K	﹤0.01%	1650
2024 Q1	$434K	Hold	43,801	–	–	﹤0.01%	1753
2023 Q4	$141K	Buy	43,801 +16,598	+61%	+$45.1K	﹤0.01%	2428
2023 Q3	$144K	Hold	27,203	–	–	﹤0.01%	2386
2023 Q2	$259K	Buy	27,203 +5,456	+25%	+$60.6K	﹤0.01%	2116
2023 Q1	$239K	Hold	21,747	–	–	﹤0.01%	2112
2022 Q4	$322K	Hold	21,747	–	–	﹤0.01%	1925
2022 Q3	$416K	Buy	21,747 +5,029	+30%	+$114K	﹤0.01%	1766
2022 Q2	$356K	Hold	16,718	–	–	﹤0.01%	1899
2022 Q1	$322K	Buy	16,718 +6,170	+58%	+$104K	﹤0.01%	2058
2021 Q4	$219K	Hold	10,548	–	–	﹤0.01%	1997
2021 Q3	$252K	Hold	10,548	–	–	﹤0.01%	1942
2021 Q2	$288K	Buy	10,548 +2,304	+28%	+$64.9K	﹤0.01%	1921
2021 Q1	$238K	Hold	8,244	–	–	﹤0.01%	1958
2020 Q4	$232K	Hold	8,244	–	–	﹤0.01%	1901
2020 Q3	$242K	Buy	8,244 +2,902	+54%	+$77.5K	﹤0.01%	1747
2020 Q2	$162K	Hold	5,342	–	–	﹤0.01%	2021
2020 Q1	$159K	Buy	+5,342	New	+$144K	﹤0.01%	1818